Everest Medicines Presents Complete Maintenance Period Data for Etrasimod at ECCO 2025

Everest Medicines Presents Complete Maintenance Period Data for Etrasimod at ECCO 2025

Data confirms significant clinical and endoscopic benefits of etrasimod 2mg after 40 weeks of maintenance treatment Etrasimod demonstrates robust efficacy across multiple endpoints, including mucosal healing, endoscopic normalization, and...

menu
menu